Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma

Surgery (United States)

Volumn 158, Issue 6, 2015, Pages 1500-1511

  Kim, Seo Ki ^a   Woo, Jung Woo ^a   Lee, Jun Ho ^a   Park, Inhye ^a   Choe, Jun Ho ^a   Kim, Jung Han ^a   Kim, Jee Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; TUMOR MARKER; BRAF PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NECK DISSECTION; PRIORITY JOURNAL; THYROID CARCINOMA; THYROIDECTOMY; AGED; CARCINOMA; CASE CONTROL STUDY; GENETICS; INCIDENCE; LYMPHATIC METASTASIS; MIDDLE AGED; MUTATION; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; THYROID NEOPLASMS; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84947031596     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.05.016     Document Type: Article

References (58)

1. L. Davies, and H.G. Welch Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA 295 2006 2164 2167
2. E.L. Mazzaferri, and S.M. Jhiang Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 1994 418 428
3. S.I. Sherman, P. Angelos, D.W. Ball, S.W. Beenken, D. Byrd, O.H. Clark, and et al. Thyroid carcinoma J Natl Compr Canc Netw 3 2005 404 457
4. S.I. Sherman, J.D. Brierley, M. Sperling, K.B. Ain, S.T. Bigos, D.S. Cooper, and et al. Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group Cancer 83 1998 1012 1021
5. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, and et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
6. M.A. Kouvaraki, S.E. Shapiro, B.D. Fornage, B.S. Edeiken-Monro, S.I. Sherman, R. Vassilopoulou-Sellin, and et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer Surgery 134 2003 946 954 discussion 54-55
7. H.E. Gonzalez, F. Cruz, A. O'Brien, I. Goni, A. Leon, R. Claure, and et al. Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma Arch Otolaryngol Head Neck Surg 133 2007 1258 1262
8. Y. Ito, and A. Miyauchi Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma World J Surg 32 2008 729 739
9. A.R. Shaha TNM classification of thyroid carcinoma World J Surg 31 2007 879 887
10. Y. Ito, T. Higashiyama, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, and et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection World J Surg 31 2007 2085 2091
11. R. Bergamaschi, G. Becouarn, J. Ronceray, and J.P. Arnaud Morbidity of thyroid surgery Am J Surg 176 1998 71 75
12. E.L. Mazzaferri, G.M. Doherty, and D.L. Steward The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma Thyroid 19 2009 683 689
13. D.J. Wingert, S.R. Friesen, J.I. Iliopoulos, G.E. Pierce, J.H. Thomas, and A.S. Hermreck Post-thyroidectomy hypocalcemia. Incidence and risk factors Am J Surg 152 1986 606 610
14. J. Jonklaas, N.J. Sarlis, D. Litofsky, K.B. Ain, S.T. Bigos, J.D. Brierley, and et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy Thyroid 16 2006 1229 1242
15. K.Y. Bilimoria, D.J. Bentrem, C.Y. Ko, A.K. Stewart, D.P. Winchester, M.S. Talamonti, and et al. Extent of surgery affects survival for papillary thyroid cancer Ann Surg 246 2007 375 381 discussion 81-84
16. K.H. Yi, Y.J. Park, S.S. Koong, J.H. Kim, D.G. Na, J.S. Ryu, and et al. Revised Korean thyroid association management guidelines for patients with thyroid nodules and thyroid cancer J Korean Soc Radiol 64 2010 389 416
17. J.M. Stulak, C.S. Grant, D.R. Farley, G.B. Thompson, J.A. van Heerden, I.D. Hay, and et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer Arch Surg 141 2006 489 494 discussion 94-96
18. Y. Ito, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, and et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid World J Surg 30 2006 91 99
19. E. Kim, J.S. Park, K.R. Son, J.H. Kim, S.J. Jeon, and D.G. Na Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography Thyroid 18 2008 411 418
20. E.S. Cibas, and S.Z. Ali The Bethesda System for Reporting Thyroid Cytopathology Thyroid 19 2009 1159 1165
21. E.K. Alexander Approach to the patient with a cytologically indeterminate thyroid nodule J Clin Endocrinol Metab 93 2008 4175 4182
22. J.L. Rabaglia, W. Kabbani, L. Wallace, S. Holt, L. Watumull, J. Pruitt, and et al. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions Surgery 148 2010 1267 1272 discussion 72-73
23. A.J. Laurie, S.G. Lyon, and E.C. Lasser Contrast material iodides: potential effects on radioactive iodine thyroid uptake J Nucl Med 33 1992 237 238
24. B. Nygaard, T. Nygaard, L.I. Jensen, M. Court-Payen, P. Soe-Jensen, K.G. Nielsen, and et al. Iohexol: effects on uptake of radioactive iodine in the thyroid and on thyroid function Acad Radiol 5 1998 409 414
25. K.E. Mercer, and C.A. Pritchard Raf proteins and cancer: B-Raf is identified as a mutational target Biochim Biophys Acta 1653 2003 25 40
26. J.A. Fagin Genetics of papillary thyroid cancer initiation: implications for therapy Trans Am Clin Climatol Assoc 116 2005 259 269 discussion 69-71
27. Y. Cohen, M. Xing, E. Mambo, Z. Guo, G. Wu, B. Trink, and et al. BRAF mutation in papillary thyroid carcinoma J Natl Cancer Inst 95 2003 625 627
28. X. Xu, R.M. Quiros, P. Gattuso, K.B. Ain, and R.A. Prinz High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines Cancer Res 63 2003 4561 4567
29. M. Xing BRAF mutation in thyroid cancer Endocr Relat Cancer 12 2005 245 262
30. K.H. Kim, D.W. Kang, S.H. Kim, I.O. Seong, and D.Y. Kang Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population Yonsei Med J 45 2004 818 821
31. T.Y. Kim, W.B. Kim, J.Y. Song, Y.S. Rhee, G. Gong, Y.M. Cho, and et al. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma Clin Endocrinol (Oxf) 63 2005 588 593
32. S.K. Kim, D.L. Kim, H.S. Han, W.S. Kim, S.J. Kim, W.J. Moon, and et al. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules Diagn Mol Pathol 17 2008 118 125
33. J.A. Knauf, X. Ma, E.P. Smith, L. Zhang, N. Mitsutake, X.H. Liao, and et al. Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation Cancer Res 65 2005 4238 4245
34. C. Mesa Jr., M. Mirza, N. Mitsutake, M. Sartor, M. Medvedovic, C. Tomlinson, and et al. Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling Cancer Res 66 2006 6521 6529
35. M. Xing BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications Endocr Rev 28 2007 742 762
36. M. Xing, D. Clark, H. Guan, M. Ji, A. Dackiw, K.A. Carson, and et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer J Clin Oncol 27 2009 2977 2982
37. E. Kebebew, J. Weng, J. Bauer, G. Ranvier, O.H. Clark, Q.Y. Duh, and et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer Ann Surg 246 2007 466 470 discussion 70-71
38. C. Lupi, R. Giannini, C. Ugolini, A. Proietti, P. Berti, M. Minuto, and et al. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma J Clin Endocrinol Metab 92 2007 4085 4090
39. L. Yip, M.N. Nikiforova, S.E. Carty, J.H. Yim, M.T. Stang, M.J. Tublin, and et al. Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation Surgery 146 2009 1215 1223
40. J.K. Nam, C.K. Jung, B.J. Song, D.J. Lim, B.J. Chae, N.S. Lee, and et al. Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer? Am J Surg 203 2012 436 441
41. H.J. Moon, J.Y. Kwak, E.K. Kim, J.R. Choi, S.W. Hong, M.J. Kim, and et al. The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology Ann Surg Oncol 16 2009 3125 3131
42. L. Fugazzola, D. Mannavola, V. Cirello, G. Vannucchi, M. Muzza, L. Vicentini, and et al. BRAF mutations in an Italian cohort of thyroid cancers Clin Endocrinol (Oxf) 61 2004 239 243
43. R.T. Liu, Y.J. Chen, F.F. Chou, C.L. Li, W.L. Wu, P.C. Tsai, and et al. No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan Clin Endocrinol (Oxf) 63 2005 461 466
44. A. Proietti, R. Giannini, C. Ugolini, M. Miccoli, G. Fontanini, G. Di Coscio, and et al. BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features Thyroid 20 2010 1263 1270
45. American Thyroid Association Surgery Working G American Association of Endocrine S American Academy of O-H S. Neck, H. American, S. Neck, and et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer Thyroid 19 2009 1153 1158
46. A. Antonelli, P. Miccoli, M. Ferdeghini, G. Di Coscio, B. Alberti, P. Iacconi, and et al. Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer Thyroid 5 1995 25 28
47. P.W. Rosario, S. de Faria, L. Bicalho, M.F. Alves, M.A. Borges, S. Purisch, and et al. Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma J Ultrasound Med 24 2005 1385 1389
48. M. Ying, A. Ahuja, and C. Metreweli Diagnostic accuracy of sonographic criteria for evaluation of cervical lymphadenopathy J Ultrasound Med 17 1998 437 445
49. T. Uruno, A. Miyauchi, K. Shimizu, C. Tomoda, Y. Takamura, Y. Ito, and et al. Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer World J Surg 29 2005 483 485
50. F. Boi, G. Baghino, F. Atzeni, M.L. Lai, G. Faa, and S. Mariotti The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies J Clin Endocrinol Metab 91 2006 1364 1369
51. M. Cignarelli, A. Ambrosi, A. Marino, O. Lamacchia, M. Campo, G. Picca, and et al. Diagnostic utility of thyroglobulin detection in fine-needle aspiration of cervical cystic metastatic lymph nodes from papillary thyroid cancer with negative cytology Thyroid 13 2003 1163 1167
52. C.L. Snozek, E.P. Chambers, C.C. Reading, T.J. Sebo, J.W. Sistrunk, R.J. Singh, and et al. Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases J Clin Endocrinol Metab 92 2007 4278 4281
53. J.Y. Joo, J.Y. Park, Y.H. Yoon, B. Choi, J.M. Kim, Y.S. Jo, and et al. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study J Clin Endocrinol Metab 97 2012 3996 4003
54. Y.K. So, Y.I. Son, S.D. Hong, M.Y. Seo, C.H. Baek, H.S. Jeong, and et al. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections Surgery 148 2010 526 531
55. S. Bonnet, D. Hartl, S. Leboulleux, E. Baudin, J.D. Lumbroso, A. Al Ghuzlan, and et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment J Clin Endocrinol Metab 94 2009 1162 1167
56. J.L. Roh, J.M. Kim, and C.I. Park Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence Ann Surg Oncol 18 2011 2245 2250
57. K.W. Chung, S.K. Yang, G.K. Lee, E.Y. Kim, S. Kwon, S.H. Lee, and et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAFV600E mutation-prevalent area Clin Endocrinol (Oxf) 65 2006 660 666
58. L. Jin, T.J. Sebo, N. Nakamura, X. Qian, A. Oliveira, J.A. Majerus, and et al. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid Diagn Mol Pathol 15 2006 136 143